DarioHealth Corp. earnings releases DRIO

DarioHealth Corp. last reported quarterly results on Jul 24, 2023, for the quarter ended Jun 30, 2023. It usually reports 19–46 days after a quarter ends.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 19–46 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released Quarter Revenue Net income Diluted EPS
Jul 24, 2023
24 days after quarter end
—
ended Jun 30, 2023
—
—
—
Feb 6, 2023
37 days after quarter end
—
ended Dec 31, 2022
—
—
—
Aug 15, 2022
46 days after quarter end
—
ended Jun 30, 2022
—
—
—
Jan 19, 2022
19 days after quarter end
—
ended Dec 31, 2021
—
—
—
Aug 16, 2021
47 days after quarter end
—
ended Jun 30, 2021
—
—
—

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
DRIO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1533998
Former names
LabStyle Innovations Corp. (until Jul 27, 2016)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.